Progress of research on influence of 5-hydroxytryptamine related gene polymorphisms on therapeutic response of antipsychotic drugs

王医成,王连生
DOI: https://doi.org/10.3867/j.issn.1000-3002.2010.02.013
2010-01-01
Abstract:5-Hydroxytryptamine (serotonin) is one of the most important central neurotransmitters that are also the modulation points of many psychotropic drugs. 5-Hydroxytryptamine related genes, including tryptophan hydroxylase, 5-serotonin transporter, 5-serotonin receptor and G-protein coupled-receptor, have polymorphisms among various populations. Considerable clinical trials have shown that some polymorphisms significantly influenced the efficacy of 5-hydroxytryptamine related antipsychotic drugs. Some genotypes display better therapeutic efficacy, while some display more favorable adverse reaction and good tolerance. Such information implicates the hereditary rule of the clinical response of corresponding psychotropic drugs, and indicate a way to rationally use psychotropic drugs clinically. Meanwhile, due to the ethnic heterogeneity of volunteers involved, complexity of mental disorder and related drug therapy evaluation, and limitations of genotype methods used in current investigations, results of related research on the impact of a polymorphic gene mutation sometimes vary considerably, reflecting the difficulty facing this sphere of research. Thus, it is more important to point out the direction of development for studies or for pharmacogenetics and finally pave the way for better therapeutic efficacy and security for antipsychotic drugs.
What problem does this paper attempt to address?